Cite

MLA Citation

    M Molina et al.. “DI-028 Reasons for changing treatment to oral agents in multiple sclerosis.” European journal of hospital pharmacy, vol. 24, n.d., p. A125. http://access.bl.uk/ark:/81055/vdc_100135159936.0x000006
  
Back to record